Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Companion Animals

Set Alert for Companion Animals

Kane, Dechra expand distribution agreement to South America

Canadian firm Kane Biotech and Dechra Pharmaceuticals have expanded their licence and distribution agreement to include South America.

South America Dechra Pharmaceuticals

Antech launches molecular diagnostic tests for canine cancer

Antech Diagnostics has introduced Cadet BRAF and BRAF-Plus liquid biopsy-based cancer diagnostics to North America.

Diagnostics Cancer

Bayer canine otitis externa treatment get EU positive opinion

European authorities have paved the way for Bayer Animal Health's Neptra Otic Solution canine ear drops to be approved.

Bayer Animal Health Canine

RVC study finds early neutering of dogs heightens incontinence risk

A study by the UK's Royal Veterinary College (RVC) has revealed the age at which female dogs are neutered is associated with early-onset urinary incontinence (UI).

Canine Research

KindredBio set for EU introduction as Mirataz gets positive opinion

Kindred Biosciences has gained an EU positive opinion for its Mirataz therapeutic for weight loss management in cats.

Europe Kindred Biosciences

Boehringer completes $76m Georgia vaccine site expansion

Boehringer Ingelheim Animal Health has completed the expansion of its R&D and manufacturing plant in Athens, Georgia.

Boehringer Ingelheim Animal Health Vaccines

Prevalence of pathogenic agents in Tokyo pet stores revealed

The Tokyo metropolitan government said it is important for pet stores to establish a proper quarantine to ensure pathogens are nullified on their premises.

Japan Companion Animals

University of Melbourne examines inflammation role in equine insulin dysregulation

Researchers at the University of Melbourne (UoM) are working to determine if low-grade systemic inflammation can be a cause of insulin dysregulation in horses. 

Research Equine

Elanco handed supplemental approval for Credelio tablets

Elanco has received a supplemental approval from the US FDA for its Credelio antiparasitic that adds a preventative indication to the product.

Elanco Antiparasitics

Medterra CBD bags NASC approval, enters Baylor R&D pact

US firm Medterra CBD has received an approval for its line of cannabidiol (CBD) products by the National Animal Supplement Council (NASC).

Product Approvals Pharmaceuticals

Stem cell breakthrough expected to back heart condition research in cats

Researchers have created pluripotent stem cells from domestic cats, which could potentially help to develop treatments for heart disease in both cats and humans.

Research R&D

PharmAust to gain R&D tax rebate for canine cancer trials

Australian oncology firm PharmAust is close to securing an R&D tax rebate for its canine cancer-focused trials.

R&D Pharmaceuticals
See All